Report on the viability of iNSCs and EXs In Vivo

Initially, inject fluorescently labelled EXs isolated from conditioned media of iRNSCs contralaterally in tumour -bearing animals. Assess migration and intracellular trafficking with daily intravital microscopy and weekly ex vivo fluorescent confocal microscopy over 6 weeks. Verify functional integrity with fluorescence quantification in brain and IDH1 miRNA upregulation in tumour cells. Identify Median Effective Dose (ED50) and correlate with iRNSCs numbers to be used in proof-of-concept studies.